Atlas Trials

DualityBio Inc.

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch DualityBio Inc.

RecordFirmDate
A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors (NCT07263594)DualityBio Inc.2026-01-20
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors (NCT06953089)DualityBio Inc.2025-07-18
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors (NCT06554795)DualityBio Inc.2024-09-03
A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer (NCT06265428)DualityBio Inc.2024-01-29
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) (NCT06018337)DualityBio Inc.2024-01-18
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors (NCT05914116)DualityBio Inc.2023-08-17
A Study of DB-1310 in Advanced/Metastatic Solid Tumors (NCT05785741)DualityBio Inc.2023-08-17
A Study of DB-1202 Monotherapy in Advanced Solid Tumors (NCT05785728)DualityBio Inc.2023-06-28
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors (NCT05438329)DualityBio Inc.2022-07-19
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors (NCT05150691)DualityBio Inc.2022-01-31

Track DualityBio Inc. automatically

Every clearance here is in the API, with alerts when new ones post.